Clinical trials
Autism Spectrum Disorder trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 12 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Unknown status | 12 |
| Not yet recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| King's College London | 9 |
| Hoffmann-La Roche | 4 |
| Institut de Recherches Internationales Servier | 2 |
| Midlands Psychology CIC | 2 |
| Sussex Community NHS Foundation Trust | 2 |
| University of Nottingham | 2 |
| Aberystwyth University | 1 |
| Bioprojet | 1 |
| Brightlobe Limited | 1 |
| Celso Arango, MD, PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autism Spectrum Disorder | 50 |
| Autistic Disorder | 15 |
| Attention Deficit Disorder with Hyperactivity | 6 |
| Neurodevelopmental Disorders | 4 |
| Anxiety Disorders | 2 |
| Intellectual Disability | 2 |
| Mental Disorders | 2 |
| Angelman Syndrome | 1 |
| Asperger Syndrome | 1 |
| Asthma | 1 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.